Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors
© 2023 Japan Society of Hepatology..
AIMS: Both diet and exercise counseling are recommended for patients with fatty liver, including nonalcoholic fatty liver disease (NAFLD), to achieve weight loss goals. However, data evaluating treatment efficacy are limited.
METHODS: The subjects of this retrospective cohort study were 186 consecutive Japanese cases with fatty liver diagnosed by abdominal ultrasonography. Treatment efficacy and predictive factors of "Hospitalization Program for Improvement Purpose for Fatty Liver" as a combined diet and aerobic and resistance exercise program were evaluated according to the hospitalization group (153 cases) or the no hospitalization group (33 cases). To balance the confounding biases, treatment efficacy was evaluated using propensity score-matched analysis. In the hospitalization group, a diet of 25-30 kcal/kg multiplied by ideal body weight (BW) daily and aerobic and resistance exercise (exercise intensity of 4-5 metabolic equivalents daily, respectively) were performed for 6 days.
RESULTS: In liver function tests and BW at 6 months compared with baseline, the rates of decrease of the hospitalization group (24 cases) were significantly higher than those of the no hospitalization group (24 cases), using propensity score-matched analysis. In markers of glycolipid metabolism and ferritin levels, the rates of the hospitalization group were not different from those of the no hospitalization group. In the hospitalization group (153 cases), multivariate regression analysis identified the etiology of non-NAFLD, the presence of diabetes mellitus, and large waist circumference as independent predictors of decreased rates of hemoglobin A1c levels.
CONCLUSION: The diet and exercise program for fatty liver improved liver function tests and BW. Further study should be performed to develop a feasible and suitable program.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Hepatology research : the official journal of the Japan Society of Hepatology - 53(2023), 7 vom: 08. Juli, Seite 607-617 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Akuta, Norio [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Body weight |
|---|
| Anmerkungen: |
Date Revised 04.07.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1111/hepr.13897 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353973416 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353973416 | ||
| 003 | DE-627 | ||
| 005 | 20231226061221.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/hepr.13897 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1179.xml |
| 035 | |a (DE-627)NLM353973416 | ||
| 035 | |a (NLM)36891614 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Akuta, Norio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 04.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 Japan Society of Hepatology. | ||
| 520 | |a AIMS: Both diet and exercise counseling are recommended for patients with fatty liver, including nonalcoholic fatty liver disease (NAFLD), to achieve weight loss goals. However, data evaluating treatment efficacy are limited | ||
| 520 | |a METHODS: The subjects of this retrospective cohort study were 186 consecutive Japanese cases with fatty liver diagnosed by abdominal ultrasonography. Treatment efficacy and predictive factors of "Hospitalization Program for Improvement Purpose for Fatty Liver" as a combined diet and aerobic and resistance exercise program were evaluated according to the hospitalization group (153 cases) or the no hospitalization group (33 cases). To balance the confounding biases, treatment efficacy was evaluated using propensity score-matched analysis. In the hospitalization group, a diet of 25-30 kcal/kg multiplied by ideal body weight (BW) daily and aerobic and resistance exercise (exercise intensity of 4-5 metabolic equivalents daily, respectively) were performed for 6 days | ||
| 520 | |a RESULTS: In liver function tests and BW at 6 months compared with baseline, the rates of decrease of the hospitalization group (24 cases) were significantly higher than those of the no hospitalization group (24 cases), using propensity score-matched analysis. In markers of glycolipid metabolism and ferritin levels, the rates of the hospitalization group were not different from those of the no hospitalization group. In the hospitalization group (153 cases), multivariate regression analysis identified the etiology of non-NAFLD, the presence of diabetes mellitus, and large waist circumference as independent predictors of decreased rates of hemoglobin A1c levels | ||
| 520 | |a CONCLUSION: The diet and exercise program for fatty liver improved liver function tests and BW. Further study should be performed to develop a feasible and suitable program | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a body weight | |
| 650 | 4 | |a diet and exercise | |
| 650 | 4 | |a fatty liver | |
| 650 | 4 | |a glycolipid metabolism | |
| 650 | 4 | |a hospitalization | |
| 650 | 4 | |a liver function | |
| 700 | 1 | |a Kawamura, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Fujiyama, Shunichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Nakamichi, Kenichi |e verfasserin |4 aut | |
| 700 | 1 | |a Saegusa, Eiji |e verfasserin |4 aut | |
| 700 | 1 | |a Ogura, Hidetoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Kato, Masaki |e verfasserin |4 aut | |
| 700 | 1 | |a Doi, Etsuko |e verfasserin |4 aut | |
| 700 | 1 | |a Inoue, Naoko |e verfasserin |4 aut | |
| 700 | 1 | |a Sezaki, Hitomi |e verfasserin |4 aut | |
| 700 | 1 | |a Hosaka, Tetsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Mariko |e verfasserin |4 aut | |
| 700 | 1 | |a Saitoh, Satoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Arase, Yasuji |e verfasserin |4 aut | |
| 700 | 1 | |a Ikeda, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Yoshiyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kumada, Hiromitsu |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Fumitaka |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hepatology research : the official journal of the Japan Society of Hepatology |d 1998 |g 53(2023), 7 vom: 08. Juli, Seite 607-617 |w (DE-627)NLM096511133 |x 1386-6346 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2023 |g number:7 |g day:08 |g month:07 |g pages:607-617 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/hepr.13897 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2023 |e 7 |b 08 |c 07 |h 607-617 | ||